Brain stimulation,
Journal Year:
2024,
Volume and Issue:
17(1), P. 83 - 88
Published: Jan. 1, 2024
No
study
on
neurostimulation
in
narcolepsy
is
available
until
now.
Arousal-
and
wake-promoting
effects
of
vagus
nerve
stimulation
(VNS)
have
been
demonstrated
animal
experiments
are
well-known
as
side
VNS
therapy
epilepsy
depression.
The
objective
was
to
evaluate
the
therapeutic
effect
daily
sleepiness
cataplexies
narcolepsy.
In
our
open-label
prospective
comparative
study,
we
included
patients
who
were
treated
with
because
depression
or
compared
them
controls
without
for
(18
each
group,
aged
31.5
±
8.2
years).
We
evaluated
(Epworth
Sleepiness
Scale,
ESS)
number
per
week
before
implantation
at
three
six
month
follow-ups.
Compared
baseline
(ESS:
15.9
2.5)
showed
a
significant
improvement
ESS
after
months
(11.2
3.3,
p
<
0.05)
(9.6
2.8,
0.001)
trend
reduction
cataplexies.
ESS-improvement
observed
(14.9
3.9,
13.6
3.7,
13.2
3.5,
=
0.2
baseline,
months,
correspondingly).
Side
did
not
differ
between
groups.
this
first
evaluation
narcolepsy,
found
due
type
neurostimulation.
could
be
promising
non-medical
treatment
Frontiers in Human Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: June 29, 2023
Vagus
nerve
stimulation
(VNS)
has
been
recognized
as
a
useful
neuromodulation
tool
to
target
the
central
nervous
system
by
electrical
of
peripheral
nerves.
Activation
nucleus
solitary
tract
(NTS)
in
brainstem
vagal
afferent
fibers
allows
for
modulation
various
higher
order
brain
regions,
including
limbic
and
cerebral
cortex
structures.
Along
with
neurological
psychiatric
indications,
clinical
preclinical
studies
suggest
that
VNS
can
improve
memory.
While
underlying
mechanisms
memory
involve
areas,
such
prefrontal
processes
alertness
arousal,
here
we
focus
on
VNS-induced
improvements
related
hippocampus,
main
area
implicated
acquisition.
In
addition,
detail
research
demonstrating
targeted
approach
modify
outcomes
delve
into
molecular
associated
these
changes.
These
findings
indicate
greater
understanding
while
also
considering
parameters,
administration
site,
timing
relation
training,
sex-specific
factors,
may
allow
optimal
application
enhance
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Feb. 13, 2024
Abstract
Inflammation,
caused
by
accumulation
of
inflammatory
cytokines
from
immunocytes,
is
prevalent
in
a
variety
diseases.
Electro-stimulation
emerges
as
promising
candidate
for
inhibition.
Although
electroacupuncture
free
surgical
injury,
it
faces
the
challenges
imprecise
pathways/current
spikes,
and
insufficiently
defined
mechanisms,
while
non-optimal
pathway
or
spike
would
require
high
current
amplitude,
which
makes
electro-stimulation
usually
accompanied
damage
complications.
Here,
we
propose
neuromorphic
based
on
atomically
thin
semiconductor
floating-gate
memory
interdigital
circuit.
Direct
stimulation
achieved
wrapping
sympathetic
chain
with
flexible
electrodes
are
programmable
to
fire
bionic
thus
minimizing
nerve
damage.
A
substantial
decrease
(73.5%)
cytokine
IL-6
occurred,
also
enabled
better
efficacy
than
commercial
stimulator
at
record-low
currents
damage-free
neurons.
Additionally,
using
transgenic
mice,
anti-inflammation
effect
determined
β2
adrenergic
signaling
myeloid
cell
lineage
(monocytes/macrophages
granulocytes).
Brain stimulation,
Journal Year:
2024,
Volume and Issue:
17(2), P. 460 - 468
Published: March 1, 2024
BackgroundWorking
memory
is
essential
to
a
wide
range
of
cognitive
functions
and
activities.
Transcutaneous
auricular
VNS
(taVNS)
promising
method
improve
working
performance.
However,
the
feasibility
scalability
electrical
stimulation
are
constrained
by
several
limitations,
such
as
discomfort
inconsistent
contact.ObjectiveWe
aimed
develop
novel
practical
method,
vibrotactile
taVNS,
memory.
Further,
we
investigated
its
effects
on
arousal,
measured
skin
conductance
pupil
diameter.MethodThis
study
included
20
healthy
participants.
Behavioral
response,
conductance,
eye
tracking
data
were
concurrently
recorded
while
participants
performed
N-back
tasks
under
three
conditions:
taVNS
delivered
cymba
concha,
earlobe
(sham
control),
no
(baseline
control).ResultsIn
4-back
tasks,
which
demand
maximal
capacity,
active
significantly
improved
performance
metric
compared
baseline
but
not
sham.
Moreover,
found
that
reduction
rate
with
increasing
task
difficulty
was
smaller
during
sessions
than
in
both
sham
conditions.
Arousal,
diameter,
declined
over
course
tasks.
Vibrotactile
rescued
this
arousal
decline,
leading
levels
corresponding
optimal
levels.
diameter
level
higher
high-cognitive-load
when
concha
sham.ConclusionOur
findings
suggest
modulates
pathway
could
be
potential
intervention
for
enhancing
Psychophysiology,
Journal Year:
2025,
Volume and Issue:
62(1)
Published: Jan. 1, 2025
Abstract
Transcutaneous
vagus
nerve
stimulation
(tVNS)
offers
a
non‐invasive
method
to
enhance
noradrenergic
neurotransmission
in
the
human
brain,
thereby
increasing
cognitive
control.
Here,
we
investigate
if
changes
control
induced
by
tVNS
are
mediated
through
locus
coeruleus‐induced
modifications
of
neural
activity
anterior
cingulate
cortex.
Young
healthy
participants
engaged
simple
task
focusing
on
response
inhibition
and
more
complex
that
involved
both
working
memory,
inside
magnetic
resonance
imaging
scanner.
The
tasks
were
executed
using
randomized
within‐subject
design,
with
undergoing
auricular
sham
separate
sessions.
significantly
changed
performance
reflected
greater
propensity
respond.
Furthermore,
observed
significant
increase
cortex
during
under
tVNS.
Functional
connectivity
analyses
revealed
positive
coupling
between
coeruleus
cortex,
however,
this
was
not
modulated
findings
suggest
can
modulate
While
these
effects
an
impact
key
region
conflict
monitoring
control,
behavioral
indicative
shift
bias
rather
than
enhanced
Current Issues in Molecular Biology,
Journal Year:
2025,
Volume and Issue:
47(2), P. 122 - 122
Published: Feb. 14, 2025
Over
the
past
three
decades,
vagus
nerve
stimulation
(VNS)
has
emerged
as
a
promising
rehabilitation
therapy
for
diverse
range
of
conditions,
demonstrating
substantial
clinical
potential.
This
review
summarizes
in
vivo
biological
mechanisms
activated
by
VNS
and
their
corresponding
applications.
Furthermore,
it
outlines
selection
parameters
equipment
implementation.
exhibits
anti-inflammatory
effects,
modulates
neurotransmitter
release,
enhances
neural
plasticity,
inhibits
apoptosis
autophagy,
maintains
blood-brain
barrier
integrity,
promotes
angiogenesis.
Clinically,
been
utilized
treatment
epilepsy,
depression,
headache,
stroke,
obesity.
Its
potential
applications
extend
to
management
cardiovascular
cerebrovascular
diseases
various
brain
disorders.
However,
further
experiments
are
required
definitively
establish
efficacy
VNS's
mechanisms.
Additionally,
there
is
need
explore
identify
optimal
different
diseases.
Frontiers in Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: Feb. 16, 2022
Stroke
poses
a
serious
threat
to
human
health
and
burdens
both
society
the
healthcare
system.
Standard
rehabilitative
therapies
may
not
be
effective
in
improving
functions
after
stroke,
so
alternative
strategies
are
needed.
The
FDA
has
approved
vagus
nerve
stimulation
(VNS)
for
treatment
of
epilepsy,
migraines,
depression.
Recent
studies
have
demonstrated
that
VNS
can
facilitate
benefits
rehabilitation
interventions.
coupled
with
upper
limb
enhances
recovery
function
patients
chronic
stroke.
However,
its
invasive
nature
limits
clinical
application.
Researchers
developed
non-invasive
method
stimulate
(non-invasive
stimulation,
nVNS).
It
been
suggested
nVNS
could
promising
muscle
stroke
patients.
In
this
article,
we
review
current
researches
preclinical
as
well
potential
applications
We
summarize
parameters,
advantages,
mechanisms,
adverse
effects
applications,
future
challenges
directions
cerebral
treatment.
These
indicate
efficacy
reducing
volume
attenuating
neurological
deficits
ischemic
models.
While
more
basic
research
is
required
fully
understand
mechanisms
efficacy,
especially
Phase
III
trials
large
number
patients,
these
data
suggest
applied
easily
only
possible
secondary
prophylactic
but
also
adjunctive
acute
near
future.
Brain stimulation,
Journal Year:
2022,
Volume and Issue:
15(5), P. 1279 - 1289
Published: Sept. 1, 2022
BackgroundMaintaining
energy
homeostasis
is
vital
and
supported
by
vagal
signaling
between
digestive
organs
the
brain.
Previous
research
has
established
a
gastric
network
in
brain
that
phase
synchronized
with
rhythm
of
stomach,
but
tools
to
perturb
its
function
were
lacking.ObjectiveTo
evaluate
whether
stomach-brain
coupling
can
be
acutely
increased
non-invasively
stimulating
afferent
projections
brain.MethodsUsing
single-blind
randomized
crossover
design,
we
investigated
effect
acute
right-sided
transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
versus
sham
on
coupling.ResultsIn
line
preclinical
research,
taVNS
nucleus
solitary
tract
(NTS)
midbrain
while
boosting
across
Crucially,
cortex,
taVNS-induced
changes
occurred
primarily
transmodal
regions
associated
hunger
ratings
as
indicators
subjective
metabolic
state.ConclusionstaVNS
increases
via
an
NTS-midbrain
pathway
signals
gut-induced
reward,
indicating
communication
body
effectively
modulated
vago-vagal
signaling.
Such
insights
may
help
us
better
understand
role
afferents
orchestrating
recruitment
which
could
pave
way
for
novel
neuromodulatory
treatments.
Brain stimulation,
Journal Year:
2023,
Volume and Issue:
16(4), P. 1001 - 1008
Published: June 20, 2023
Transcutaneous
auricular
vagus
nerve
stimulation
(taVNS)
has
been
tested
as
a
potential
treatment
for
pharmaco-resistant
epilepsy
and
depression.
Its
clinical
efficacy
is
thought
to
depend
on
taVNS-induced
activation
of
the
locus
coeruleus
other
neuromodulator
systems.
However,
unlike
invasive
VNS
in
rodents,
there
little
evidence
an
effect
taVNS
noradrenergic
activity.We
attempted
replicate
recently
published
findings
by
Sharon
et
al.
(2021),
showing
that
short
bursts
transiently
increased
pupil
size
decreased
EEG
alpha
power,
two
correlates
central
activity.Following
original
study,
we
used
single-blind,
sham-controlled,
randomized
cross-over
design.
Human
volunteers
(n
=
29)
received
short-term
(3.4
s)
at
maximum
level
below
pain
threshold,
while
collected
resting-state
pupil-size
data.
To
analyze
data,
scripts
provided
colleagues.Consistent
with
dilation
was
significantly
larger
during
than
sham
(p
.009;
Bayes
factor
supporting
difference
7.45).
failed
power
.37);
data
were
four
times
more
likely
under
null
hypothesis
(BF10
0.28).Our
support
effectiveness
inducing
transient
dilation,
correlate
phasic
activity.
recent
finding
(2021)
attenuates
Overall,
this
study
highlights
need
continued
research
neural
mechanisms
underlying
its
option
conditions.
It
also
direct
replications
influential
studies.